Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenABCWY Booster Extension Study
NCT01992536Phase 2Completed
- Sponsor
- Novartis
- Start
- Dec 2013
- Primary completion
- May 2014
- Modality
- Split/Subunit Vaccines
- Countries
- 2
01
Overview
A Phase 2 trial of Meningococcal ABCWY in meningococcal disease, sponsored by Novartis. Started Dec 2013; status: completed.
02
Drugs
Meningococcal ABCWY
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT01992536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01992536.